The Effect of Exclusion Diet for Crohn's Disease Plus Enteral Nutrition on Children and Adolescents With Crohn's Disease
1 other identifier
interventional
44
0 countries
N/A
Brief Summary
In this study, children and adolescents with active Crohn's disease are placed in two intervention groups, the first group receives only an exclusion diet and the second group receives an exclusion diet plus formula.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2024
CompletedFirst Posted
Study publicly available on registry
April 9, 2024
CompletedStudy Start
First participant enrolled
April 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2024
CompletedApril 9, 2024
April 1, 2024
6 months
February 23, 2024
April 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
PCDAI
pediatric chron disease activity index
8 weeks
CRP
c-reactive protein
8 weeks
ESR
erythrocyte sedimentation rate
8 weeks
FC
fecal calprotectin
8 weeks
Alb
serum albumin
8 weeks
Secondary Outcomes (4)
Arm Circumferance
8 weeks
BMI
8 weeks
Height
8 weeks
weight
8 weeks
Study Arms (2)
exclusion diet along with formula
ACTIVE COMPARATORA group that receives only exclusion diet
ACTIVE COMPARATORInterventions
The calories needed by the person are calculated and half of the calories are provided by formulas and the other half based on the elimination diet
In this group, only the elimination diet is considered as an intervention
Eligibility Criteria
You may qualify if:
- children aged 4 to 18 years with active Crohn's disease
- Pediatric Crohn's Disease Activity Index (PCDAI) ≥10 and ≤40
You may not qualify if:
- Patients who receiving concurrent remission-inducing drugs such as steroids, 5-ASA, methotrexate, or antibiotics, as well as patients receiving induction doses of a biologic
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Azita Hekmatdoost, MD, PhD
NNFTRI
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 23, 2024
First Posted
April 9, 2024
Study Start
April 10, 2024
Primary Completion
October 20, 2024
Study Completion
December 25, 2024
Last Updated
April 9, 2024
Record last verified: 2024-04